Technology area: Biotechnology & Pharmaceuticals
7 pending office actions • 6 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
Natural Extraction Systems LLC has 7 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are spread across 7 distinct examiners, which is a high degree of distribution. The matters are distributed among 6 distinct art units, indicating a broad range of technical review for the company's applications. This wide distribution requires practitioners to manage 7 separate prosecution tracks, each with its own unique technical and procedural challenges. The presence of 6 distinct art units shows that the company is exploring multiple facets of the Biotechnology & Pharmaceuticals field.
BAKSHI, PANCHAM is the busiest examiner for this portfolio, currently managing 1 pending office action. No single examiner is managing more than 1 of the 7 pending office actions. This means that practitioners must coordinate with 7 distinct examiners, each with their own unique prosecution style and history. Managing 7 pending office actions across 6 distinct art units requires significant administrative oversight to track various deadlines and response requirements. The company's focus on the Biotechnology & Pharmaceuticals area is evident from the volume of active matters. Practitioners should look for common themes across the 7 pending office actions to develop a more efficient and unified prosecution strategy. This diversity of examiners and units suggests a broad and varied technological focus for the company's current patent applications.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (14%) |
| §103 only | 1 (14%) |
| Double-patenting only | 2 (29%) |
| Double-patenting + other | 1 (14%) |
| Multi-statute (no §101) | 2 (29%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BAKSHI, PANCHAM | 1 | 76.7% | +30.2% |
| JOHNSON, CHRISTOPHER LINDSAY | 1 | 48.6% | +78.3% |
| RAO, PADMAJA S | 1 | 70.7% | +36.8% |
| OTTON, ALICIA L | 1 | 65.0% | +9.3% |
| JARRELL, NOBLE E | 1 | 80.9% | +10.0% |
| BORI, IBRAHIM D | 1 | 43.9% | +39.0% |
| CAIN, JENNIFER LYNN | 1 | 43.5% | +67.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18309646 | GAS PHASE METHODS TO DECARBOXYLATE CANNABINOIDS | JARRELL, NOBLE E | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18560625 | Methods to synthesize cyclopentenes and cyclopentadienes by ring contraction | BAKSHI, PANCHAM | — |
| 18546085 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | JOHNSON, CHRISTOPHER LINDSAY | — |
| 17784059 | COMPOSITIONS COMPRISING NOVEL CANNABINOID AND TERPENE PROFILES | BORI, IBRAHIM D | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18560625 | Methods to synthesize cyclopentenes and cyclopentadienes by ring contraction | BAKSHI, PANCHAM | — |
| 18546085 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | JOHNSON, CHRISTOPHER LINDSAY | — |
| 18546084 | COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS | RAO, PADMAJA S | — |
| 18309646 | GAS PHASE METHODS TO DECARBOXYLATE CANNABINOIDS | JARRELL, NOBLE E | — |
| 17784059 | COMPOSITIONS COMPRISING NOVEL CANNABINOID AND TERPENE PROFILES | BORI, IBRAHIM D | — |
| 17621879 | CONTAINERS, COMPOSITIONS, AND METHODS RELATED TO CANNABINOID ANIONS | CAIN, JENNIFER LYNN | — |
| Art Unit | Apps |
|---|---|
| 1699 | 2 |
| 1623 | 1 |
| 1691 | 1 |
| 1627 | 1 |
| 1629 | 1 |
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18560625 | Methods to synthesize cyclopentenes and cyclopentadienes by ring contraction | BAKSHI, PANCHAM | 1623 | §102§103 | Final Rejection | — | Pending | Nov 13, 2023 |
| 18546085 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | JOHNSON, CHRISTOPHER LINDSAY | 1691 | §103§112 | Non-Final OA | — | Pending | Aug 10, 2023 |
| 18546084 | COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS | RAO, PADMAJA S | 1627 | §103§112DP | Non-Final OA | — | Pending | Aug 10, 2023 |
| 18328547 | METHODS TO PURIFY CANNABINOIDS | OTTON, ALICIA L | 1699 | DP | Non-Final OA | — | Pending | Jun 02, 2023 |
| 18309646 | GAS PHASE METHODS TO DECARBOXYLATE CANNABINOIDS | JARRELL, NOBLE E | 1699 | DP | Non-Final OA | — | Pending | Apr 28, 2023 |
| 17784059 | COMPOSITIONS COMPRISING NOVEL CANNABINOID AND TERPENE PROFILES | BORI, IBRAHIM D | 1629 | §101§103§112 | Non-Final OA | — | Pending | Jun 09, 2022 |
| 17621879 | CONTAINERS, COMPOSITIONS, AND METHODS RELATED TO CANNABINOID ANIONS | CAIN, JENNIFER LYNN | 1655 | §103Other | Final Rejection | — | Pending | Dec 22, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNatural Extraction Systems LLC has 7 pending office actions as of October 2026, spread across 6 art units and 7 examiners.
Pancham Bakshi has the most, with 1 of Natural Extraction Systems LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
